Decades ago, severe thalassemia sharply reduced life expectancy. Today, regular transfusions, iron chelation therapy, improved monitoring, and bone marrow transplants have helped many patients live far longer. Gene-based treatments have also entered clinical use in some countries, though access remains limited and highly specialised.